Medical device companies face a complex landscape when determining their clinical evidence requirements. The path forward depends on multiple factors including device classification, predicate devices, and regulatory pathway. Understanding these requirements early in development can mean the difference between a smooth regulatory submission and costly delays. This oversight can derail product launches and strain resources… Read more